Colorado Blood Cancer Institute (CBCI) — Denver, Colorado

Colorado Blood Cancer Institute (CBCI) is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Colorado Blood Cancer Institute (CBCI) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia, Waldenstrom Macroglobulinemia.

Sponsors: Autolus Limited, Massachusetts General Hospital.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Blood Cancer Institute (CBCI)?

Colorado Blood Cancer Institute (CBCI) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Blood Cancer Institute (CBCI) conducted?

Colorado Blood Cancer Institute (CBCI) has 2 clinical trials on record, with 2 currently active. Their work covers Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia, Waldenstrom Macroglobulinemia.

Is Colorado Blood Cancer Institute (CBCI) accredited by Crixeo Health?

Colorado Blood Cancer Institute (CBCI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Blood Cancer Institute (CBCI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.